|
|
|
Sunday, March 2, 2008 — 8:30 AM, Convention Center 201/203
|
- Coronary Artery Disease and Myocardial Infarction in the Era of Interventional Cardiology
|
|
Moderators:
|
Barbara Sampson, Office of Chief Medical Examiner, New York, NY and Gaetano Thiene, Università degli Studi di Padova, Padova, Italy
|
|
|
Disclosure:
|
In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. Dr. John Carroll indicated he receives grant/research support from Cordis Johnson & Johnson, Boston Scientific, and Medtronic. Dr. Renu Virmani indicated she is a consultant receives grant/research support from companies listed on attached. All other faculty members for this Symposium have indicated they have no disclosures to make.
|
Click the button above to add this event to your Itinerary Planner...
 Click here to view (or print) handout in single page format for the entire meeting.
Note: Any slides will be printed in color.
Click here to view (or print) black and white handout for the entire meeting
Note: Text will be in single page format and any slides will be in 6-per-page format.
Click any blue title below to display and print the handout for individual lecture(s):
| 8:30 | Introduction: Myocardial Infarction, A Paradigm of Success in Modern
Medicine - Gaetano Thiene, Università degli Studi di Padova, Padova, Italy |
| 8:45 | The Vulnerable and Unstable Plaque - Michael C. Fishbein, University
of California, Los Angeles, CA |
| 9:10 | The Pathology of Myocardial Infarction Following Coronary
Recanalization - Cristina Basso, Università degli Studi di Padova, Padova, Italy |
| 9:35 | Unresolved Issues in Myocardial Reperfusion Injury - L. Maximilian
Buja, University of Texas Health Science Center, Houston, TX |
| 10:00 | Break |
| 10:30 | Interventional Procedures for Relieving Myocardial Ischemia - John Carroll, University of
Colorado Health Sciences Center Denver, CO |
| 10:55 | The Dilemma of Bare or Drug Eluting Stents - Renu Virmani, Armed
Forces Institute of Pathology, Washington, DC |
| 11:20 | Lecture SCVP Award - Myocardial Infatuation: A Light-Hearted Look at a Lion-Hearted Organ - William D. Edwards, Mayo Clinic, Rochester, MN
|
|
Myocardial infarction is a major cause of morbility and mortality even in East countries. However,
great advances have been achieved in the early diagnosis and treatment. The decreased mortality from
myocardial infarction, due to aggressive interventional cardiology and monitoring in coronary care units
is a paradigm of the success of modern medicine. Pathology played a major role in determining the time
of irreversible myocardial ischemia injury for early treatment. |
|
|
|
